Oncology Industry
Insights & Trends
January 9, 2025
Clinical trials, a critical component of the drug development process, often face
severe delays contributing to costs and inefficiencies in bringing the drug to the market.
To address this problem
December 23, 2024
Beyond CI Teams: A Strategic Intelligence Platform Guide for Pharma R&D, BD, and Biotech Leaders The reality of modern drug development is clear. Whether juggling multiple […]
January 22, 2024
Print Report LinkedIn Oncology Clinical Trials: Outlook and Emerging Trials by Hunter Moody, Gayathri Devi, Aparna Jadhav Introduction Kognitic uses Artificial Intelligence/Machine Learning to transform pharmaceutical […]
January 18, 2024
Print Report Conferences Dashboard LinkedIn ASH 2023 Rapid Insights: Acute Myeloid Leukemia by Hunter Moody and Gayathri Devi ASH 2023 will feature the latest updates and […]
November 8, 2023
Print Report LinkedIn Post ctDNA in Oncology: Current Landscape and Future Potential by Jyoti Pant and Hunter Moody Circulating tumor DNA (ctDNA) is a type of […]
October 19, 2023
Print Report ESMO Dashboard LinkedIn ESMO 2023 Emerging Trends: A Preview of Abstracts by Hunter Moody ESMO will once again showcase the latest groundbreaking therapies and […]
June 23, 2023
Print Report LinkedIn Post Exploring Boundless Potential AI Revolutionizes Oncology at ASCO 2023 by Gayathri Raghupathy As a company artistically merging the realms of science and […]
March 23, 2023
Print Report CURRENT LANDSCAPE OF CELL THERAPY CLINICAL TRIALS The first cell therapy (Provenge) to treat cancer got FDA approval in 2010. Following the approval of […]
May 24, 2021
COVID Vaccines, what’s new: an update on the latest clinical trials that are underway with the currently administered vaccines The global pandemic posed a challenge for […]